Prescribed Medications for Acute Treatment of Migraine Market Size, Demand Analysis 2022
The global prescribed medications for acute treatment of migraine Market size was valued at USD 2,587.9 million in 2021 and is poised to grow at a significant CAGR of 13.7% during the forecast period 2022-28. The market for prescribed medications for acute treatment of migraine is expected to offer lucrative opportunities for the market players due to the launch of novel molecules in the U.S. market. The companies have focused on novel therapeutics, an alternative to the triptan class of drugs due to the adverse effects like cardiovascular disorders, chest pressure, and others. Novel treatment options and increased prevalence of migraine are expected to drive the market. Increased awareness initiatives, the availability of research funds from private and public bodies, a development in the reimbursement scenario for associated medications, and increasing awareness about the effectiveness of such medicines are among the significant factors fuelling the market's growth. Furthermore, rising pharmaceutical R&D operating costs and rising healthcare spending are expected to drive the global prescribed medications for acute migraine treatment market growth rate during the forecast period.
View Detailed Report Description Here - https://precisionbusinessinsights.com/market-reports/global-prescribed-medication-for-acute-treatment-for-migrane-market
Abortive prescribed medications segment Dominates the Prescribed Medications for Acute Treatment of Migraine Market
In the prescribed medications for acute treatment of migraine market, abortive prescribed medications for acute treatment of migraine accounted for a larger revenue share in 2021 and are projected to grow with a CAGR of 13.9% from 2020-2026 to reach US$ 1,653.7 Mn by 2026. However, the market for prophylactic drugs is anticipated to grow with a significant CAGR over the forecast years in prescribed medications for acute treatment of migraine. The increasing awareness of novel drug classes and the rising incidence of migraine problems worldwide drive the target market's growth. Additionally, factors such as increasing work pressure, high alcohol consumption, growing demand for quality drugs, changes in lifestyles, and awareness among patients associated with the prevention and treatment of migraine further increase the demand levels for the global prescribed medications for acute treatment of migraine market. The increasing precedence of other therapies and side effects associated with migraine drugs limit the growth of the Prescribed Medications for Acute Migraine Treatment Market.
The global prescribed medications for acute treatment of migraine market segmentation:
- By Drug Type: Abortive and Prophylactic
- By Route of Administration: Oral, Injectables, and Others
- By Distribution Channel: Hospital Pharmacies, Retail pharmacies, and Online Pharmacies
North America Leads Prescribed Medications for Acute Treatment of Migraine Market
North America Prescribed Medications for Acute Treatment of Migraine market held the highest market share of 60.8% in 2021. Favorable reimbursements for migraine medications, a growing emphasis on precision medicine, increased awareness about various migraine medications, and well-established market players in the region are among the key factors driving the market growth for prescribed medications for acute migraine treatment in this region. In addition, Europe will be the second-largest shareholder owing to the high development of generic drugs is available at a low cost and the subsequent support from governments across several countries for these drugs.
Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=40858
Key player’s profiles in the prescribed medications for acute treatment of migraine market report are Biohaven Pharmaceuticals, Merck & Co., Inc., Pfizer Inc., Astrazeneca, Eli Lilly and Company, Avanir Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Allergan.
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights| Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian